All Stories

  1. What does PrEP mean for ‘safe sex’ norms? A qualitative study
  2. Trans and gender diverse people’s experiences of healthcare access in Australia: A qualitative study in people with complex needs
  3. Attitudes and Perceived Social Norms toward Drug Use among Gay and Bisexual Men in Australia
  4. The binding practices of transgender and gender-diverse adults in Sydney, Australia
  5. National leadership needed on HIV Pre-exposure Prophylaxis (PrEP) access in Australia
  6. Ebola “Ring” Vaccine Trial Was Ethically Innovative
  7. Communities need to be equal partners in determining whether research is acceptable
  8. “Reasonable Availability” Criterion Remains Salient
  9. Critical role of ethics in clinical management and public health response to the West Africa Ebola epidemic
  10. The Health Care Consequences Of Australian Immigration Policies
  11. Ebola vaccine development plan: ethics, concerns and proposed measures
  12. Ebola: what it teaches us about medical ethics. A response to Angus Dawson
  13. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence – a narrative review
  14. Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?
  15. HIV transmission law in the age of treatment-as-prevention
  16. S15.4 The unmet need and potential application of mpts for rectal use: implications for women and msm at risk of stis and hiv
  17. Prioritization of healthcare workers for experimental Ebola therapeutic would exacerbate existing inequalities
  18. Stakeholders’ engagement with Ebola therapy research in resource limited settings
  19. Ethical Testing of Experimental Ebola Treatments
  20. Considering Pre-Exposure Prophylaxis: Do the Pros Outweigh the Cons as an HIV Prevention Strategy?
  21. Compassionate use of experimental drugs in the Ebola outbreak
  22. Ethical challenges for doctors working in immigration detention
  23. It’s Time: The Case for PrEP as an Active Comparator in HIV Biomedical Prevention Trials
  24. Debating Ethics in HIV Research: Gaps between Policy and Practice in Nigeria
  25. Ethical Issues in Adolescents' Sexual and Reproductive Health Research in Nigeria
  26. Mind the gap: An empirical study of post-trial access in HIV biomedical prevention trials
  27. Standard of Prevention in the Real World: A Qualitative Study of Principal Investigators in HIV Biomedical Prevention Trials
  28. Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials: Examining PrEP
  29. Ethics of ARV Based Prevention: Treatment-as-Prevention and PrEP
  30. The seventh (and last?) International Microbicides Conference: from discovery to delivery
  31. Ethics of medical care and clinical research: a qualitative study of principal investigators in biomedical HIV prevention research
  32. How Good Is “Good Enough”? The Case for Varying Standards of Evidence According to Need for New Interventions in HIV Prevention
  33. Treatment-as-Prevention Needs to Be Considered in the Just Allocation of HIV Drugs
  34. BECAUSE WE CAN: CLASHES OF PERSPECTIVE OVER RESEARCHER OBLIGATION IN THE FAILED PrEP TRIALS
  35. No Sex Please in Sexuality Research
  36. Back to Basics in Clinical Research Ethics